BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 11489990)

  • 1. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A.
    Staples KJ; Bergmann M; Tomita K; Houslay MD; McPhee I; Barnes PJ; Giembycz MA; Newton R
    J Immunol; 2001 Aug; 167(4):2074-80. PubMed ID: 11489990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
    Eckly-Michel A; Martin V; Lugnier C
    Br J Pharmacol; 1997 Sep; 122(1):158-64. PubMed ID: 9298542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: effects of silencing CREB gene expression on Akt activation.
    Misra UK; Pizzo SV
    J Biol Chem; 2005 Nov; 280(46):38276-89. PubMed ID: 16172130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
    Moon EY; Lee GH; Lee MS; Kim HM; Lee JW
    Life Sci; 2012 Feb; 90(9-10):373-80. PubMed ID: 22227470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis.
    Tiwari S; Felekkis K; Moon EY; Flies A; Sherr DH; Lerner A
    Blood; 2004 Apr; 103(7):2661-7. PubMed ID: 14615375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89.
    Meja KK; Catley MC; Cambridge LM; Barnes PJ; Lum H; Newton R; Giembycz MA
    J Pharmacol Exp Ther; 2004 May; 309(2):833-44. PubMed ID: 14747610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1.
    Alava MA; DeBell KE; Conti A; Hoffman T; Bonvini E
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):189-99. PubMed ID: 1318020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cAMP elevating agents on carbachol-induced phosphoinositide hydrolysis and calcium mobilization in cultured canine tracheal smooth muscle cells.
    Yang CM; Hsu MC; Tsao HL; Chiu CT; Ong R; Hsieh JT; Fan LW
    Cell Calcium; 1996 Mar; 19(3):243-54. PubMed ID: 8732264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rolipram, salbutamol and prostaglandin E2 suppress TNFalpha release from human monocytes by activating Type II cAMP-dependent protein kinase.
    Seldon PM; Meja KK; Giembycz MA
    Pulm Pharmacol Ther; 2005; 18(4):277-84. PubMed ID: 15777610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of thapsigargin-induced calcium mobilisation by cyclic AMP-elevating agents in human lymphocytes is insensitive to the action of the protein kinase A inhibitor H-89.
    de la Rosa LA; Vilariño N; Vieytes MR; Botana LM
    Cell Signal; 2001 Jun; 13(6):441-9. PubMed ID: 11384843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38.
    Schulte G; Fredholm BB
    Exp Cell Res; 2003 Oct; 290(1):168-76. PubMed ID: 14516797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway.
    Maes M; Kenis G; Kubera M; De Baets M; Steinbusch H; Bosmans E
    Int Immunopharmacol; 2005 Mar; 5(3):609-18. PubMed ID: 15683856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells.
    Delghandi MP; Johannessen M; Moens U
    Cell Signal; 2005 Nov; 17(11):1343-51. PubMed ID: 16125054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of IL-5 production to the cAMP-dependent pathway in human T cells is reduced by exogenous IL-2 in a phosphoinositide 3-kinase-dependent way.
    Heijink IH; Kauffman HF; Postma DS; de Monchy JG; Vellenga E
    Eur J Immunol; 2003 Aug; 33(8):2206-15. PubMed ID: 12884295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of pharmacological elevation of cyclic AMP in T lymphocytes proceed via a protein kinase A independent mechanism.
    Bryce PJ; Dascombe MJ; Hutchinson IV
    Immunopharmacology; 1999 Feb; 41(2):139-46. PubMed ID: 10102795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway.
    Borger P; Kauffman HF; Postma DS; Vellenga E
    Blood; 1996 Jan; 87(2):691-8. PubMed ID: 8555492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inhibitor of cAMP-dependent protein kinase induces behavioural and neurological antidepressant-like effects in rats.
    Liebenberg N; Müller HK; Fischer CW; Harvey BH; Brink CB; Elfving B; Wegener G
    Neurosci Lett; 2011 Jul; 498(2):158-61. PubMed ID: 21596096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rap1 activation plays a regulatory role in pancreatic amylase secretion.
    Sabbatini ME; Chen X; Ernst SA; Williams JA
    J Biol Chem; 2008 Aug; 283(35):23884-94. PubMed ID: 18577515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytes.
    Kadoshima-Yamaoka K; Murakawa M; Goto M; Tanaka Y; Inoue H; Murafuji H; Nagahira A; Hayashi Y; Nagahira K; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
    Immunol Lett; 2009 Feb; 122(2):193-7. PubMed ID: 19195485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
    Tamir A; Granot Y; Isakov N
    J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.